Importantly, increased levels of tumor infiltrating CD8+ T cell and tumor-reactive IFNγ+ CD8+ T cells by the combination treatment of anti-PD-1 and siHmgcr-CNPs were reversed upon Lip-1 treatment (Fig. 2e, f). This evidence concerns the gene CD8A and neoplasm.